Post-acute withdrawal syndrome is an underresearched topic that affects many patients with substance use disorders after the cessation of substance use. Post-acute withdrawal syndrome is exemplified by the occurrence of substance-specific withdrawal signs and symptoms lasting well past the known timeframe for acute withdrawal of a used substance. Post-acute withdrawal syndrome may also include signs and symptoms that are not substance specific that persist, evolve, or appear well past the expected acute withdrawal timeframe. Unfortunately, there is very little scientific literature on post-acute withdrawal syndrome. As a result of this, there are no diagnostic criteria for post-acute withdrawal syndrome, and there is no consensus on the proper name for the condition. We present a case of a 38-year-old man who developed post-acute withdrawal syndrome after treatment with buprenorphine for opioid use disorder and review the limited existing literature on post-acute withdrawal syndrome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/ADM.0000000000001047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardiac manifestations of post-acute withdrawal syndrome from a history of synthetic cathinone and opioid use.
Med J Malaysia
November 2024
Non-Commercial Joint-Stock Company "Semey Medical University", Abay St. 103, Semey, Kazakhstan.
Article Synopsis
- Synthetic cathinones and opioids are prevalent illicit drugs in Central Asia, with many users experiencing poly-dependence and associated cardiovascular health risks.
- A study involving 294 patients assessed the cardiac effects of these drugs through electrocardiography and echocardiography, revealing significant differences in heart function measurements between users of synthetic cathinones and opioids.
- The findings showed that both groups exhibited issues like left ventricular hypertrophy and reduced ejection fraction, highlighting the need for further research on cardiac complications in patients undergoing post-acute withdrawal syndrome.
Caring for Coma after Severe Brain Injury: Clinical Practices and Challenges to Improve Outcomes: An Initiative by the Curing Coma Campaign.
Neurocrit Care
October 2024
Department of Neurology and Neurosurgery Federal University of São Paulo, Universidade Federal De Sao Paulo, and Hospital Israelita Albert Einstein, São Paulo, Brazil.
Severe brain injury can result in disorders of consciousness (DoC), including coma, vegetative state/unresponsive wakefulness syndrome, and minimally conscious state. Improved emergency and trauma medicine response, in addition to expanding efforts to prevent premature withdrawal of life-sustaining treatment, has led to an increased number of patients with prolonged DoC. High-quality bedside care of patients with DoC is key to improving long-term functional outcomes.
View Article and Find Full Text PDFDelayed Withdrawal of Life-Sustaining Treatment in Disorders of Consciousness: Practical and Theoretical Considerations.
Neurocrit Care
October 2024
Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Disorders of consciousness (DoC) resulting from severe acute brain injuries may prompt clinicians and surrogate decision makers to consider withdrawal of life-sustaining treatment (WLST) if the neurologic prognosis is poor. Recent guidelines suggest, however, that clinicians should avoid definitively concluding a poor prognosis prior to 28 days post injury, as patients may demonstrate neurologic recovery outside the acute time period. This practice may increase the frequency with which clinicians consider the option of delayed WLST (D-WLST), namely, WLST that would occur after hospital discharge, if the patient's recovery trajectory ultimately proves inconsistent with an acceptable quality of life.
View Article and Find Full Text PDFEffects of yoga compared with health promotion on health-related quality of life in adults with post-COVID-19 condition: protocol for a randomised controlled trial.
BMJ Open
September 2024
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
Introduction: Post-COVID-19 condition (post COVID, also known as long COVID) is a global public health issue estimated to affect over 100 million people. Common symptoms include fatigue, dyspnoea and cognitive dysfunction ('brain fog'). Over time, these symptoms have an adverse effect on mental health, physical activity and quality of life (QoL).
View Article and Find Full Text PDFAntiseizure Medication Withdrawal, Risk of Epilepsy, and Longterm EEG Trends in Acute Symptomatic Seizures or Epileptic EEG Patterns.
Neurol Clin Pract
December 2024
Comprehensive Epilepsy Center (AS, AT, RJ, KNK, NR, EJG, LJH), Department of Neurology, Yale University School of Medicine, New Haven, CT; Columbia University Medical Center (AT), New York, NY; Horizon Therapeutics (NR); Division of Neurocritical Care and Emergency Neurology (JAK, EJG), Department of Neurology, Yale University School of Medicine, New Haven, CT.
Background And Objectives: Patients with acute symptomatic seizures (ASyS) and acute epileptiform findings on EEG are common. They are often prescribed long-term antiseizure medications (ASMs); it is unknown whether or when this is necessary. Primary outcome was late unprovoked seizure occurrence and association with ASM taper.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!